Liverpool Hospital, Liverpool, NSW, Australia.
South West Sydney Clinical School, The University of New South Wales, New South Wales, Australia.
Eur J Pediatr. 2022 Jul;181(7):2619-2632. doi: 10.1007/s00431-021-04365-9. Epub 2022 Apr 28.
Paediatric intestinal pseudo-obstruction (PIPO) encompasses a group of rare disorders in which patients present with the clinical features of bowel obstruction in the absence of mechanical occlusion. The management of PIPO presents a challenge as evidence remains limited on available medical and surgical therapy. Parenteral nutrition is often the mainstay of therapy. Long-term therapy may culminate in life-threatening complications including intestinal failure-related liver disease, central line thrombosis and sepsis. Intestinal transplantation remains the only definitive cure in PIPO but is a complex and resource-limited solution associated with its own morbidity and mortality. We conducted a scoping review to present a contemporary summary of the epidemiology, aetiology, pathophysiology, diagnosis, management and complications of PIPO.Conclusion: PIPO represents a rare disorder that is difficult to diagnose and challenging to treat, with significant morbitity and mortality. The only known cure is intestinal transplantation. What is Known: • Paediatric intestinal pseudo-obstruction is a rare, heterogeneous disorder that confers a high rate of morbidity and mortality • Complications of paediatric intestinal pseudo-obstruction include chronic pain, small intestine bacterial overgrowth and malrotation. Other complications can occur related to its management, such as line infections with parenteral nutrition or cardiac side effects of prokinetic medications What is New: • Progress in medical and surgical therapy in recent years has led to improved patient outcomes • Enteral autonomy has been reported in most patients at as early as 1 month post-transplantation.
小儿肠假性梗阻 (PIPO) 涵盖了一组罕见疾病,这些疾病的患者在没有机械阻塞的情况下表现出肠梗阻的临床特征。由于目前可用的医学和手术治疗的证据仍然有限,因此 PIPO 的治疗具有挑战性。肠外营养通常是治疗的主要方法。长期治疗可能会导致危及生命的并发症,包括与肠衰竭相关的肝病、中心静脉血栓形成和败血症。肠移植仍然是 PIPO 的唯一根治方法,但它是一种复杂且资源有限的解决方案,存在自身发病率和死亡率。我们进行了范围审查,以展示 PIPO 的流行病学、病因、病理生理学、诊断、治疗和并发症的当代总结。结论:PIPO 代表一种罕见的疾病,难以诊断,治疗具有挑战性,发病率和死亡率很高。唯一已知的治疗方法是肠移植。已知:•小儿肠假性梗阻是一种罕见的、异质性疾病,导致高发病率和死亡率。小儿肠假性梗阻的并发症包括慢性疼痛、小肠细菌过度生长和旋转不良。其他并发症可能与它的管理有关,例如肠外营养的线路感染或促动力药物的心脏副作用。新内容:•近年来医学和手术治疗的进展导致了患者预后的改善。•在移植后最早的 1 个月,大多数患者的肠内自主功能已经恢复。